Klaus F. Rabe
- COPD and ComorbidityEdited by Klaus F. Rabe, Jadwiga A. Wedzicha and Emiel F.M. WoutersBook | Published in 2013DOI: 10.1183/1025448x.erm5913ISBN (electronic): 978-1-84984-033-0Klaus F. RabeJadwiga A. Wedzicha
- Towards a total ban on links with the tobacco industry: new rules for the ERSBy Klaus F. Rabe, Christina Gratziou, Brian Ward and Florence BertelettiKlaus F. Rabe*Krankenhaus Großhansdorf, Großhansdorf, GermanyChristina Gratziou#Evgenidio Hospital, Athens, GreeceBrian Ward¶European Respiratory SocietyFlorence Berteletti+Smoke Free Partnership, Brussels, Belgium
- Prof. Andrzej Szczeklik, 1938–2012: aspirin-induced asthma and much moreBy Sven-Erik Dahlén, Barbro Dahlén and Klaus F. RabeSven-Erik DahlénBarbro Dahlén
- The EvA study: aims and strategyBy Loems Ziegler-Heitbrock, Marion Frankenberger, Irene Heimbeck, Dorothe Burggraf, Matthias Wjst, Karl Häussinger, Chris Brightling, Sumit Gupta, David Parr, Deepak Subramanian, Dave Singh, Umme Kolsum, Piera Boschetto, Alfredo Potena, Dorota Gorecka, Adam Nowinski, Imre Barta, Balazs Döme, Janos Strausz, Timm Greulich, Claus Vogelmeier, Robert Bals, Jens M. Hohlfeld, Tobias Welte, Per Venge, Ivo Gut, Anne Boland, Robert Olaso, Jörg Hager, Pieter Hiemstra, Klaus F. Rabe, Martina Unmüßig, Joachim Müller-Quernheim and Antje PrasseLoems Ziegler-HeitbrockFor author affiliations, see the Acknowledgements sectionMarion FrankenbergerFor author affiliations, see the Acknowledgements sectionIrene HeimbeckFor author affiliations, see the Acknowledgements sectionDorothe BurggrafFor author affiliations, see the Acknowledgements sectionMatthias WjstFor author affiliations, see the Acknowledgements sectionKarl HäussingerFor author affiliations, see the Acknowledgements sectionChris BrightlingFor author affiliations, see the Acknowledgements sectionSumit GuptaFor author affiliations, see the Acknowledgements sectionDavid ParrFor author affiliations, see the Acknowledgements sectionDeepak SubramanianFor author affiliations, see the Acknowledgements sectionDave SinghFor author affiliations, see the Acknowledgements sectionUmme KolsumFor author affiliations, see the Acknowledgements sectionPiera BoschettoFor author affiliations, see the Acknowledgements sectionAlfredo PotenaFor author affiliations, see the Acknowledgements sectionDorota GoreckaFor author affiliations, see the Acknowledgements sectionAdam NowinskiFor author affiliations, see the Acknowledgements sectionImre BartaFor author affiliations, see the Acknowledgements sectionBalazs DömeFor author affiliations, see the Acknowledgements sectionJanos StrauszFor author affiliations, see the Acknowledgements sectionTimm GreulichFor author affiliations, see the Acknowledgements sectionClaus VogelmeierFor author affiliations, see the Acknowledgements sectionRobert BalsFor author affiliations, see the Acknowledgements sectionJens M. HohlfeldFor author affiliations, see the Acknowledgements sectionTobias WelteFor author affiliations, see the Acknowledgements sectionPer VengeFor author affiliations, see the Acknowledgements sectionIvo GutFor author affiliations, see the Acknowledgements sectionAnne BolandFor author affiliations, see the Acknowledgements sectionRobert OlasoFor author affiliations, see the Acknowledgements sectionJörg HagerFor author affiliations, see the Acknowledgements sectionPieter HiemstraFor author affiliations, see the Acknowledgements sectionKlaus F. RabeFor author affiliations, see the Acknowledgements sectionMartina UnmüßigFor author affiliations, see the Acknowledgements sectionJoachim Müller-QuernheimFor author affiliations, see the Acknowledgements sectionAntje PrasseFor author affiliations, see the Acknowledgements section
- Extracellular matrix composition in COPDBy Raquel Annoni, Tatiana Lanças, Ryan Yukimatsu Tanigawa, Marcus de Medeiros Matsushita, Sandra de Morais Fernezlian, Andreina Bruno, Luiz Fernando Ferraz da Silva, Peter J. Roughley, Salvatore Battaglia, Marisa Dolhnikoff, Pieter S. Hiemstra, Peter J. Sterk, Klaus F. Rabe and Thais MauadRaquel Annoni*Dept of Pathology, University of São Paulo Medical School, São PauloTatiana Lanças*Dept of Pathology, University of São Paulo Medical School, São PauloRyan Yukimatsu Tanigawa*Dept of Pathology, University of São Paulo Medical School, São PauloMarcus de Medeiros Matsushita#University of Marilia Medical School, Marilia, BrazilSandra de Morais Fernezlian*Dept of Pathology, University of São Paulo Medical School, São PauloAndreina Bruno¶Institute of Biomedicine and Molecular Immunology (IBIM), Consiglio Nazionale delle Ricerche (CNR)Luiz Fernando Ferraz da Silva*Dept of Pathology, University of São Paulo Medical School, São PauloPeter J. Roughley+Shriners Hospital for Children, McGill University, Montreal, QC, CanadaSalvatore Battaglia§Dipartimento Biomedico di Medicina Interna e Specialistica (Di.Bi.MIS), University of Palermo, Palermo, ItalyMarisa Dolhnikoff*Dept of Pathology, University of São Paulo Medical School, São PauloPieter S. HiemstrafDept of Pulmonology, Leiden University Medical Center, LeidenPeter J. Sterk**Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsKlaus F. Rabe##Dept of Medicine, University of Kiel, Kiel, GermanyThais Mauad*Dept of Pathology, University of São Paulo Medical School, São Paulo
- An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory healthBy Dean E. Schraufnagel, Francesco Blasi, Monica Kraft, Mina Gaga, Patricia Finn and Klaus F. RabeDean E. Schraufnagel1Dept of Medicine, University of Illinois at Chicago, Chicago ILFrancesco Blasi2Dept of Pathophysiology and Transplantation, University of Milan, IRCCS Fondazione Cà Granda Milan, ItalyMonica Kraft3Dept of Medicine, Duke University, Durham, NCMina Gaga4Seventh Respiratory Dept and Asthma Centre, Athens Chest Hospital, Athens, GreecePatricia Finn5Dept of Medicine, University of Illinois at Chicago, Chicago IL, USAKlaus F. Rabe6University Kiel and Krankenhaus Grosshansdorf, Grosshansdorf, Germany
- Pulmonologists and lung cancer: pivotal role in multidisciplinary approachBy Mina Gaga, Jean-Paul Sculier and Klaus F. RabeMina Gaga17th Respiratory Medicine Dept, Athens Chest Hospital, Athens, GreeceJean-Paul Sculier2Institut Jules Bordet, Brussels, BelgiumKlaus F. Rabe3Zentrum für Pneumologie und Thoraxchirurgie, Krankenhaus Großhansdorf, Großhansdorf, Germany
- Tiotropium vs salmeterol in GOLD II and maintenance-naïve COPD patients: Subgroup analyses of POET-COPD™ trialBy Kai M. Beeh, Claus Vogelmeier, Maureen P.M.H. Rutten-van Mölken, Klaus F. Rabe, Thomas Glaab, Fee Rühmkorf, Hendrik Schmidt and Leonardo M. FabbriKai M. Beeh1Dept of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, D 65187 Wiesbaden, GermanyClaus Vogelmeier2Division for Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, GermanyMaureen P.M.H. Rutten-van Mölken3Dept of Health Economics, Institute for Medical Technology Assessment (IMTA), Erasmus University, Rotterdam, NetherlandsKlaus F. Rabe4Dept of Pneumologie, Grosshansdorf Hospital, Grosshansdorf, GermanyThomas Glaab5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyFee Rühmkorf5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyHendrik Schmidt5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyLeonardo M. Fabbri6Dept of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, Italy
- Do exacerbation outcomes in the POET-COPD™ trial differ between regions?By Maureen P.M.H. Rutten-van Mölken, Leonardo M. Fabbri, Klaus F. Rabe, Harald Kögler, Thomas Glaab, Hendrik Schmidt, Kai M. Beeh and Claus VogelmeierMaureen P.M.H. Rutten-van Mölken1Department of Health Economics, Institute for Medical Technology Assessment (IMTA), Erasmus University, Rotterdam, NetherlandsLeonardo M. Fabbri2Department of Medical and Surgical Specialties, University of Modena & Reggio Emilia, Modena, ItalyKlaus F. Rabe3Department of Pneumologie, Grosshansdorf Hospital, Grosshansdorf, GermanyHarald Kögler4Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyThomas Glaab4Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyHendrik Schmidt4Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, GermanyKai M. Beeh5Department of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, GermanyClaus Vogelmeier6Division for Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, Germany
- Patient experiences of exacerbations in a real world setting: Global results from the Hidden Depths surveyBy Neil Barnes, Peter M.A. Calverley, Alan Kaplan and Klaus F. RabeNeil Barnes1Department of Respiratory Medicine, London Chest Hospital, London, United KingdomPeter M.A. Calverley2School of Clinical Sciences, University Hospital Aintree, Liverpool, United KingdomAlan Kaplan3Bedford Park Medical Centre, Richmond Hill, ON, CanadaKlaus F. Rabe4University Kiel, Department of Medicine and Krankenhaus Grosshansdorf, Center for Pulmonology and Thoracic Surgery, D-22927 Grosshansdorf, Germany
- IL-17A expression by mast cells in smokersBy Yvonne Nussbaumer-Ochsner, Luiz F. Ferraz da Silva, Klaus F. Rabe, Annemarie M. van Schadewijk, Thais Mauad and Pieter S. HiemstraYvonne Nussbaumer-Ochsner1Department of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, NetherlandsLuiz F. Ferraz da Silva2Department of Pathology, Sao Paulo University Medical Schoo, Sao Paulo, BrazilKlaus F. RabeAnnemarie M. van Schadewijk1Department of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, NetherlandsThais Mauad2Department of Pathology, Sao Paulo University Medical Schoo, Sao Paulo, BrazilPieter S. Hiemstra1Department of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, Netherlands
- Baseline characteristics of patients with frequent exacerbations in the POET-COPD™ trialBy Leonardo M. Fabbri, Claus Vogelmeier, Maureen P.M.H. Rutten-van Mölken, Klaus F. Rabe, Thomas Glaab, Fee Rühmkorf, Hendrik Schmidt and Kai M. BeehLeonardo M. Fabbri1Dept. of Medical & Surgical Specialities, University of Modena & Reggio Emilia, Modena, ItalyClaus Vogelmeier2Division of Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, GermanyMaureen P.M.H. Rutten-van Mölken3Dept. of Health Economics, Institute for Medical Technology Assessment (IMTA), Erasmus University, Rotterdam, NetherlandsKlaus F. Rabe4Dept. of Pneumologie, Grosshansdorf Hospital, Grosshansdorf, GermanyThomas Glaab5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyFee Rühmkorf5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyHendrik Schmidt5Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, GermanyKai M. Beeh6Dept. of Internal and Pulmonary Medicine, Insaf Respiratory Research Institute, Wiesbaden, Germany
- Respiratory diseases in the world: one voice “united for lung health”By Peter J. Barnes, Francesco Blasi, Brian Ward, Elin Reeves and Klaus F. RabePeter J. Barnes1National Heart and Lung Institute, Imperial College, LondonFrancesco Blasi2Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyBrian Ward3European Respiratory Society, European Affairs Dept, Brussels, BelgiumElin Reeves4European Respiratory Society, Publications Office, Sheffield, UKKlaus F. Rabe5Zentrum für Pneumologie und Thoraxchirurgie, Krankenhaus Großhansdorf, Großhansdorf, Germany
- The European Respiratory Society plans its future: the 2013–2018 strategic planBy Giovanni Battista Migliori, Klaus F. Rabe, Elisabeth Bel, Mark Elliott, Mina Gaga, Stephen T. Holgate, Guy Joos, Fernando Martin Burrieza, Betty Sax, Jean-Paul Sculier, Anita K. Simonds, Francesco Blasi and Peter J. BarnesGiovanni Battista Migliori1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate16Both authors contributed equallyKlaus F. Rabe2Dept of Internal Medicine, Christian Albrechts University Kiel, Kiel3Dept of Pulmonary Medicine, LungenClinic Grosshansdorf, Grosshansdorf4Airway Research Center North (ARCN), Grosshansdorf5German Center for Lung Research (DZL), Grosshansdorf, Germany16Both authors contributed equallyElisabeth Bel6Dept of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsMark Elliott7Respiratory Medicine, St James’s University Hospital, LeedsMina Gaga87th Respiratory Medicine Dept, Athens Chest Hospital, Athens, GreeceStephen T. Holgate9University of Southampton, SouthamptonGuy Joos10Dept Respiratory Medicine, Ghent University Hospital, GhentFernando Martin Burrieza11European Respiratory Society, Lausanne, SwitzerlandBetty Sax11European Respiratory Society, Lausanne, SwitzerlandJean-Paul Sculier12Depts of Oncological Intensive Care and Emergencies and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumAnita K. Simonds13NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, LondonFrancesco Blasi14Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyPeter J. Barnes15National Heart and Lung Institute, Imperial College, London, UK
- Correlation between airway smooth muscle (ASM) and eosinophilic inflammation in severe non-controlled asthmaticsBy Regina Maria Carvalho-Pinto, Alberto Cukier, Thais Mauad, Marisa Dolhnikoff, Marcelo Gervilla Gregório, Ruy Camargo Pires Neto, Aila Mirtes Teles, Klaus F. Rabe and Rafael StelmachRegina Maria Carvalho-Pinto1Pulmonary Division, Heart Institute (InCor) - University of São Paulo Medical School, São Paulo, SP, BrazilAlberto Cukier1Pulmonary Division, Heart Institute (InCor) - University of São Paulo Medical School, São Paulo, SP, BrazilThais Mauad2Department of Pathology, University of São Paulo Medical School, São Paulo, SP, BrazilMarisa Dolhnikoff2Department of Pathology, University of São Paulo Medical School, São Paulo, SP, BrazilMarcelo Gervilla Gregório1Pulmonary Division, Heart Institute (InCor) - University of São Paulo Medical School, São Paulo, SP, BrazilRuy Camargo Pires Neto2Department of Pathology, University of São Paulo Medical School, São Paulo, SP, BrazilAila Mirtes Teles2Department of Pathology, University of São Paulo Medical School, São Paulo, SP, BrazilKlaus F. Rabe3Zentrum für Pneumologie und Thoraxchirurgie, Krankenhaus Grosshansdorf, Grosshansdorf, GermanyRafael Stelmach1Pulmonary Division, Heart Institute (InCor) - University of São Paulo Medical School, São Paulo, SP, Brazil
- Decrease of physical activity in patients with COPD in the course of the diseaseBy Benjamin Waschki, Miriam Schaper, Anna-Lena Sack, Olaf Holz, Anne Kirsten, Thorsten Meyer, Klaus F. Rabe, Helgo Magnussen and Henrik WatzBenjamin Waschki1Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, Germany4Department of Internal Medicine II, St. Elisabeth Hospital, Straubing, GermanyMiriam Schaper1Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, GermanyAnna-Lena Sack1Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, GermanyOlaf Holz2Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Member of the German Centre for Lung Research, Grosshansdorf, Germany5Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Member of the German Centre for Lung Research, Fraunhofer Institute, Hannover, GermanyAnne Kirsten1Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, GermanyThorsten Meyer3Institute of Epidemiology, Social Medicine and Health System Research, Hannover Medical School, Hannover, GermanyKlaus F. Rabe2Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Member of the German Centre for Lung Research, Grosshansdorf, GermanyHelgo Magnussen1Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, GermanyHenrik Watz1Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, Germany
- Association of β2-adrenoreceptor genotypes with prevention of COPD exacerbations by tiotropium or salmeterol in the POET-COPD® trialBy Harald Koegler, Klaus F. Rabe, Kai M. Beeh, Thomas Glaab, Hendrik Schmidt, Leonardo M. Fabbri and Claus VogelmeierHarald Koegler1Medical Affairs Germany, Boehringer Ingelheim, Ingelheim, GermanyKlaus F. Rabe2Center of Pulmonary Diseases and Thoracic Surgery, Hospital Grosshansdorf, GermanyKai M. Beeh3Insaf, Respiratory Research Institute, Wiesbaden, GermanyThomas Glaab1Medical Affairs Germany, Boehringer Ingelheim, Ingelheim, GermanyHendrik Schmidt4Biometrics and Data Management, Boehringer Ingelheim, Ingelheim, GermanyLeonardo M. Fabbri5Department of Oncology Haematology and Respiratory Diseases, University of Modena & Reggio Emilia, Modena, ItalyClaus Vogelmeier6Division for Pulmonary Diseases, Hospital of the Universities of Giessen and Marburg, Marburg, Germany
- The association between vitamin D and FEV1 in a general population is not explained by eNOBy Willemien Thijs, Robert Prein, Frits R. Rosendaal, Saskia Middeldorp, Klaus F. Rabe, Martin den Heijer, Saskia le Cessie, Pieter S. Hiemstra and Renee de MutsertWillemien Thijs1Pulmonology, LUMC, Leiden, NetherlandsRobert Prein1Pulmonology, LUMC, Leiden, NetherlandsFrits R. Rosendaal2Clinical Epidemiology, LUMC, Leiden, NetherlandsSaskia Middeldorp3Vascular Medicine, AMC, Amsterdam, NetherlandsKlaus F. Rabe4Pulmonology and Thoracic Surgery, LungenClinic Grosshansdorf, Grosshansdorf, GermanyMartin den Heijer2Clinical Epidemiology, LUMC, Leiden, NetherlandsSaskia le Cessie5Medical Statistics, LUMC, Leiden, NetherlandsPieter S. Hiemstra1Pulmonology, LUMC, Leiden, NetherlandsRenee de Mutsert2Clinical Epidemiology, LUMC, Leiden, Netherlands
- Nebulised budesonide using a novel device in patients with oral steroid-dependent asthmaBy Claus Vogelmeier, Peter Kardos, Thomas Hofmann, Sebastian Canisius, Gerhard Scheuch, Bernhard Muellinger, Karlheinz Nocker, Guenter Menz and Klaus F. RabeArticle | Published in 2014 in European Respiratory JournalClaus Vogelmeier1Dept of Medicine, Pulmonary and Critical Care Medicine, German Center for Lung Research (DZL), University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, GermanyPeter Kardos2Respiratory Group Practice at Red Cross Maingau Hospital, Frankfurt, GermanyThomas Hofmann3Vectura GmbH, Gemuenden, Germany3Vectura GmbH, Gemuenden, GermanySebastian Canisius3Vectura GmbH, Gemuenden, GermanyGerhard Scheuch3Vectura GmbH, Gemuenden, GermanyBernhard Muellinger3Vectura GmbH, Gemuenden, GermanyKarlheinz Nocker3Vectura GmbH, Gemuenden, GermanyGuenter Menz4Aumapharma Inc., Doylestown, PA, USAKlaus F. Rabe4Aumapharma Inc., Doylestown, PA, USA
- Nebulised budesonide using a novel device in patients with oral steroid-dependent asthmaBy Claus Vogelmeier, Peter Kardos, Thomas Hofmann, Sebastian Canisius, Gerhard Scheuch, Bernhard Muellinger, Karlheinz Nocker, Guenter Menz and Klaus F. RabeArticle | Published in 2014 in European Respiratory JournalClaus Vogelmeier1Dept of Medicine, Pulmonary and Critical Care Medicine, German Center for Lung Research (DZL), University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, GermanyPeter Kardos2Respiratory Group Practice at Red Cross Maingau Hospital, Frankfurt, GermanyThomas Hofmann3Vectura GmbH, Gemuenden, Germany3Vectura GmbH, Gemuenden, GermanySebastian Canisius3Vectura GmbH, Gemuenden, GermanyGerhard Scheuch3Vectura GmbH, Gemuenden, GermanyBernhard Muellinger3Vectura GmbH, Gemuenden, GermanyKarlheinz Nocker3Vectura GmbH, Gemuenden, GermanyGuenter Menz4Aumapharma Inc., Doylestown, PA, USAKlaus F. Rabe4Aumapharma Inc., Doylestown, PA, USA
- Multi-analyte profiling of inflammatory markers in COPD sputumBy Frauke Pedersen, Gereon Lauer, Gianluca Quintini, Olaf Holz, Anne-Marie Kirsten, Helgo Magnussen, Klaus F. Rabe, Torsten Goldmann and Henrik WatzFrauke Pedersen1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyGereon Lauer1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyGianluca Quintini1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyOlaf Holz1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyAnne-Marie Kirsten1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyHelgo Magnussen1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyKlaus F. Rabe1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyTorsten Goldmann1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, GermanyHenrik Watz1DZL-ARCN, Pulmonary Research Institute at LungClinic Grosshansdorf, Grosshansdorf, Germany
- Versican, tenascin, periostin and IL-17A+ cells in severe asthmaBy Thais Mauad, Diogenes S. Ferreira, Raquel Annoni, Bianca L. Oliveira, Edgard H. Katayama, Regina M. Carvalho-Pinto, Klaus F. Rabe, Alberto Cukier, Rafael Stelmach and Marisa DolhnikoffThais Mauad1Pathology, University of São Paulo Medical School, São Paulo, BrazilDiogenes S. Ferreira1Pathology, University of São Paulo Medical School, São Paulo, BrazilRaquel Annoni1Pathology, University of São Paulo Medical School, São Paulo, BrazilBianca L. Oliveira2Medical School, University of São Paulo, São Paulo, BrazilEdgard H. Katayama2Medical School, University of São Paulo, São Paulo, BrazilRegina M. Carvalho-Pinto3Pulmonary Division, University of São Paulo Medical School, São Paulo, BrazilKlaus F. Rabe4LungenClinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyAlberto Cukier3Pulmonary Division, University of São Paulo Medical School, São Paulo, BrazilRafael Stelmach3Pulmonary Division, University of São Paulo Medical School, São Paulo, BrazilMarisa Dolhnikoff1Pathology, University of São Paulo Medical School, São Paulo, Brazil
- Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputumBy Henrik Watz, Johannes Nagelschmitz, Frauke Pedersen, Felix C. Ringshausen, Anne Kirsten, Helgo Magnussen, Klaus F. Rabe, Tobias Welte, Jessica Rademacher, Christine Rentzsch, Christian Schumann, Dmitry Zubov, Volkhart Li, Anja Schäfer and Stephan SchwersHenrik Watz2Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Center North, Member of the German Center for Lung Research, Grosshansdorf, GermanyJohannes Nagelschmitz1Global Drug Development, Bayer Pharma AG, Wuppertal, GermanyFrauke Pedersen2Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Center North, Member of the German Center for Lung Research, Grosshansdorf, GermanyFelix C. Ringshausen3Department of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research, Hannover, GermanyAnne Kirsten2Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Center North, Member of the German Center for Lung Research, Grosshansdorf, GermanyHelgo Magnussen2Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Center North, Member of the German Center for Lung Research, Grosshansdorf, GermanyKlaus F. Rabe5Lung Clinic Grosshansdorf, Airway Center North, Member of the German Center for Lung Research, Grosshansdorf, GermanyTobias Welte3Department of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research, Hannover, GermanyJessica Rademacher3Department of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research, Hannover, GermanyChristine Rentzsch1Global Drug Development, Bayer Pharma AG, Wuppertal, GermanyChristian Schumann4Clinic for Internal Medicine II, University Hospital Ulm, Ulm, GermanyDmitry Zubov1Global Drug Development, Bayer Pharma AG, Wuppertal, GermanyVolkhart Li1Global Drug Development, Bayer Pharma AG, Wuppertal, GermanyAnja Schäfer1Global Drug Development, Bayer Pharma AG, Wuppertal, GermanyStephan Schwers1Global Drug Development, Bayer Pharma AG, Wuppertal, Germany
- ERS Handbook of Respiratory Medicine (out of print)Edited by Paolo Palange and Anita K. SimondsBook | Published in 2013DOI: 10.1183/9781849840415-hba02ISBN (electronic): 978-1-84984-041-5
- Increased expression of granzymes A and B in fatal asthmaBy Raquel Annoni, Luiz Fernando F. Silva, Yvonne Nussbaumer-Ochsner, Annemarie van Schadewijk, Thais Mauad, Pieter S. Hiemstra and Klaus F. RabeArticle | Published in 2015 in European Respiratory JournalRaquel Annoni1Dept of Pathology, São Paulo University Medical School, São Paulo, Brazil4Both authors contributed equallyLuiz Fernando F. Silva1Dept of Pathology, São Paulo University Medical School, São Paulo, Brazil4Both authors contributed equallyYvonne Nussbaumer-Ochsner2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsAnnemarie van Schadewijk2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsThais Mauad1Dept of Pathology, São Paulo University Medical School, São Paulo, BrazilPieter S. Hiemstra2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsKlaus F. Rabe2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands3LungenClinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany
- Increased expression of granzymes A and B in fatal asthmaBy Raquel Annoni, Luiz Fernando F. Silva, Yvonne Nussbaumer-Ochsner, Annemarie van Schadewijk, Thais Mauad, Pieter S. Hiemstra and Klaus F. RabeArticle | Published in 2015 in European Respiratory JournalRaquel Annoni1Dept of Pathology, São Paulo University Medical School, São Paulo, Brazil4Both authors contributed equallyLuiz Fernando F. Silva1Dept of Pathology, São Paulo University Medical School, São Paulo, Brazil4Both authors contributed equallyYvonne Nussbaumer-Ochsner2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsAnnemarie van Schadewijk2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsThais Mauad1Dept of Pathology, São Paulo University Medical School, São Paulo, BrazilPieter S. Hiemstra2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsKlaus F. Rabe2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands3LungenClinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany
- Treatment of COPD and the TOnado trial: a tempest in a teapot?By Klaus F. RabeKlaus F. RabeLungenClinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany. Department of Medicine, Christian Albrechts University, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlvar AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authors
- Nebulised budesonide using a novel device in patients with oral steroid-dependent asthmaBy Claus Vogelmeier, Peter Kardos, Thomas Hofmann, Sebastian Canisius, Gerhard Scheuch, Bernhard Muellinger, Karlheinz Nocker, Guenter Menz and Klaus F. RabeClaus Vogelmeier1Dept of Medicine, Pulmonary and Critical Care Medicine, German Center for Lung Research (DZL), University Medical Center Giessen and Marburg, Philipps-University Marburg, Marburg, GermanyPeter Kardos2Respiratory Group Practice at Red Cross Maingau Hospital, Frankfurt, GermanyThomas Hofmann3Vectura GmbH, Gemuenden, Germany3Vectura GmbH, Gemuenden, GermanySebastian Canisius3Vectura GmbH, Gemuenden, GermanyGerhard Scheuch3Vectura GmbH, Gemuenden, GermanyBernhard Muellinger3Vectura GmbH, Gemuenden, GermanyKarlheinz Nocker3Vectura GmbH, Gemuenden, GermanyGuenter Menz4Aumapharma Inc., Doylestown, PA, USAKlaus F. Rabe4Aumapharma Inc., Doylestown, PA, USA
- Increased expression of granzymes A and B in fatal asthmaBy Raquel Annoni, Luiz Fernando F. Silva, Yvonne Nussbaumer-Ochsner, Annemarie van Schadewijk, Thais Mauad, Pieter S. Hiemstra and Klaus F. RabeRaquel Annoni1Dept of Pathology, São Paulo University Medical School, São Paulo, Brazil4Both authors contributed equallyLuiz Fernando F. Silva1Dept of Pathology, São Paulo University Medical School, São Paulo, Brazil4Both authors contributed equallyYvonne Nussbaumer-Ochsner2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsAnnemarie van Schadewijk2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsThais Mauad1Dept of Pathology, São Paulo University Medical School, São Paulo, BrazilPieter S. Hiemstra2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The NetherlandsKlaus F. Rabe2Dept of Pulmonology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands3LungenClinic Grosshansdorf, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany
- Unmet needs for the assessment of small airways dysfunction in asthma: introduction to the ATLANTIS studyBy Dirkje S. Postma, Chris Brightling, Leo Fabbri, Thys van der Molen, Gabriele Nicolini, Alberto Papi, Klaus F. Rabe, Salman Siddiqui, Dave Singh, Maarten van den Berge and Monica KraftDirkje S. Postma1University of Groningen, University Medical Center Groningen, Dept of Pulmonology, Groningen, The NetherlandsChris Brightling2Dept of Infection, Immunity and Inflammation, Institute for Lung Health, University of Leicester, Leicester, UKLeo Fabbri3Dept of Oncology Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyThys van der Molen4University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsGabriele Nicolini5Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyAlberto Papi6Dept of Respiratory Medicine, University of Ferrara, Ferrara, ItalyKlaus F. Rabe7Dept of Medicine, Christian Albrechts University Kiel, Kiel and LungenClinic Grosshansdorf, Grosshansdorf, Germany (Members of the German Center for Lung Research (DZL))Salman Siddiqui8Dept of Infection, Immunity and Inflammation, Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, UKDave Singh9Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester, Manchester, UKMaarten van den Berge1University of Groningen, University Medical Center Groningen, Dept of Pulmonology, Groningen, The NetherlandsMonica Kraft10Dept of Medicine, University of Arizona Health Sciences Center, Tucson, AZ, USA
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar A. Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlvar A. AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section
- Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapyBy Fernando J. Martinez, Peter M.A. Calverley, Udo-Michael Goehring, Rachel Hodge, Leonardo M. Fabbri and Klaus F. RabeFernando J. Martinez1Department of Medicine, Weill Cornell Medical College, New York, United StatesPeter M.A. Calverley2Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United KingdomUdo-Michael Goehring3Takeda Development Centre Europe Ltd, Takeda Development Centre Europe Ltd, London, United KingdomRachel Hodge3Takeda Development Centre Europe Ltd, Takeda Development Centre Europe Ltd, London, United KingdomLeonardo M. Fabbri4Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, ItalyKlaus F. Rabe5Department of Medicine, Christian-Albrechts University Kiel, Kiel, Germany
- Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patientsBy Frauke Pedersen, Sebastian Marwitz, Torsten Goldmann, Anne Kirsten, Helgo Magnussen, Klaus F. Rabe, Mohib Uddin and Henrik WatzFrauke Pedersen1Respiratory Medicine, LungClinic Grosshansdorf, Grosshansdorf, Germany4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, GermanySebastian Marwitz2Clinical and Experimental Pathology, Research Center, Borstel, GermanyTorsten Goldmann2Clinical and Experimental Pathology, Research Center, Borstel, GermanyAnne Kirsten4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, GermanyHelgo Magnussen4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, GermanyKlaus F. Rabe1Respiratory Medicine, LungClinic Grosshansdorf, Grosshansdorf, GermanyMohib Uddin3Translational Science, Astra Zeneca, Mölndal, SwedenHenrik Watz4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, Germany
- Assessing small airway impairment in mild-to-moderate smoking asthmatic patientsBy Marco Contoli, Federico Bellini, Luca Morandi, Giacomo Forini, Stefano Bianchi, Giulia Gnesini, Brunilda Marku, Klaus F. Rabe and Alberto PapiArticle | Published in 2016 in European Respiratory JournalMarco Contoli1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyFederico Bellini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyLuca Morandi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyGiacomo Forini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyStefano Bianchi2Dept of Pharmacy, University Hospital of Ferrara, Ferrara, ItalyGiulia Gnesini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyBrunilda Marku1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyKlaus F. Rabe3LungClinic Grosshansdorf, Member of the German Center for Lung Research, Grosshansdorf, Germany4Dept of Medicine, Christian Albrechts University Kiel, Member of the German Center for Lung Research, Kiel, GermanyAlberto Papi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- Assessing small airway impairment in mild-to-moderate smoking asthmatic patientsBy Marco Contoli, Federico Bellini, Luca Morandi, Giacomo Forini, Stefano Bianchi, Giulia Gnesini, Brunilda Marku, Klaus F. Rabe and Alberto PapiMarco Contoli1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyFederico Bellini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyLuca Morandi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyGiacomo Forini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyStefano Bianchi2Dept of Pharmacy, University Hospital of Ferrara, Ferrara, ItalyGiulia Gnesini1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyBrunilda Marku1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, ItalyKlaus F. Rabe3LungClinic Grosshansdorf, Member of the German Center for Lung Research, Grosshansdorf, Germany4Dept of Medicine, Christian Albrechts University Kiel, Member of the German Center for Lung Research, Kiel, GermanyAlberto Papi1Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
- ERS Handbook of Respiratory MedicineEdited by Paolo Palange and Gernot RohdeBook | Published in 2019DOI: 10.1183/9781849840798.erh01ISBN (electronic): 978-1-84984-079-8
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.